Cubist Systematic Strategies, LLC Enochian Biosciences Inc Transaction History

Cubist Systematic Strategies, LLC

  • $14.3 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
N/A
19,994 New
19,994 $91,000
Q3 2023

Nov 14, 2023
BUY
$0.0 - $4.46 $0 - $48,618
10,901 New
10,901 $48,000
Q2 2022

Aug 15, 2022
BUY
$1.93 - $8.73 $25,263 - $114,275
13,090 Added 101.47%
25,990 $50,000
Q1 2022

May 16, 2022
SELL
$4.42 - $9.0 $91,489 - $186,291
-20,699 Reduced 61.61%
12,900 $106,000
Q4 2021

Feb 14, 2022
BUY
$6.71 - $12.55 $15,332 - $28,676
2,285 Added 7.3%
33,599 $245,000
Q3 2021

Nov 15, 2021
BUY
$4.56 - $7.88 $142,791 - $246,754
31,314 New
31,314 $211,000

Others Institutions Holding ENOB

# of Institutions
38
Shares Held
14M
Call Options Held
33.7K
Put Options Held
0
View Full List

About Enochian Biosciences Inc

ENOB Quotes by TradingView
  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email